Literature DB >> 7735584

Circulating interleukin-6 levels in patients with bronchial asthma.

A Yokoyama1, N Kohno, S Fujino, H Hamada, Y Inoue, S Fujioka, S Ishida, K Hiwada.   

Abstract

Circulating interleukin-6 (IL-6) levels were determined using a sensitive enzyme immunoassay in adults with asthma in stable condition during naturally occurring attacks and before and after allergen inhalation tests. IL-6 was significantly elevated even in asymptomatic asthmatic subjects (n = 17) compared with normal control subjects (n = 17). During naturally occurring asthmatic attacks, serum IL-6 levels were significantly elevated in comparison with those in a symptom-free condition (4 wk interval; n = 8, p < 0.01). No significant difference was observed in serum IL-6 levels obtained from control asymptomatic asthmatic subjects during the period (n = 10). There was a significant elevation in circulating IL-6 levels in eight asthmatic patients following inhalation of allergen but not methacholine. These results suggest that IL-6 is involved in the pathophysiology of bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735584     DOI: 10.1164/ajrccm.151.5.7735584

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  70 in total

Review 1.  Complex interactions in complex traits: obesity and asthma.

Authors:  K G Tantisira; S T Weiss
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  IL-6 receptor α defines effector memory CD8+ T cells producing Th2 cytokines and expanding in asthma.

Authors:  Naeun Lee; Sungyong You; Min Sun Shin; Won-Woo Lee; Ki Soo Kang; Sang Hyun Kim; Wan-Uk Kim; Robert J Homer; Min-Jong Kang; Ruth R Montgomery; Charles S Dela Cruz; Albert C Shaw; Patty J Lee; Geoffrey L Chupp; Daehee Hwang; Insoo Kang
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 21.405

3.  Serum interleukins 6 and 8 in mild and severe asthmatic patients, is it difference?

Authors:  Javad Ghaffari; Ali Reza Rafiei; Abolghasem Ajami; Mohammadreza Mahdavi; Bahareh Hoshiar
Journal:  Caspian J Intern Med       Date:  2011

4.  Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma.

Authors:  James B Johnson; Warren Summer; Roy G Cutler; Bronwen Martin; Dong-Hoon Hyun; Vishwa D Dixit; Michelle Pearson; Matthew Nassar; Richard Telljohann; Richard Tellejohan; Stuart Maudsley; Olga Carlson; Sujit John; Donald R Laub; Mark P Mattson
Journal:  Free Radic Biol Med       Date:  2006-12-14       Impact factor: 7.376

5.  Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions.

Authors:  Brian C Ward; Sandra Kavalukas; Jamie Brugnano; Adrian Barbul; Alyssa Panitch
Journal:  J Surg Res       Date:  2011-02-23       Impact factor: 2.192

6.  Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics.

Authors:  V Quaedvlieg; M Henket; J Sele; R Louis
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

7.  A case of haemorrhagic cystitis by inhaled salbutamol and salmeterol.

Authors:  Sonia Radice; Anna Milanesi; Stefania Antoniazzi; Valentina Perrone; Carla Carnovale; Emilio Clementi
Journal:  Eur J Clin Pharmacol       Date:  2011-06-03       Impact factor: 2.953

8.  Interleukin-6 as a biomarker for asthma: hype or is there something else?

Authors:  Matthew E Poynter; Charles G Irvin
Journal:  Eur Respir J       Date:  2016-10       Impact factor: 16.671

Review 9.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

10.  Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells.

Authors:  Wei Duan; Takanori So; Michael Croft
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.